Skip to contents

Changelog

Source: NEWS.md

posologyr v1.2.7

  • All vignettes are moved to articles
  • The updates to poso_simu_pop() in v1.2.5 introduced several issues and have been reverted
  • The new function poso_replace_et() enables updating a model with events from a new rxode2 event table, while accounting for and interpolating any covariates or inter-occasion variability

posologyr v1.2.6

CRAN release: 2024-08-27

  • Use undirected quotes when quoting in the DESCRIPTION (as requested by CRAN)
  • CRAN test times have been reduced by using an environment variable to identify the development machine, which now determines whether less critical tests are executed (as requested by CRAN)

posologyr v1.2.5

Additional feature

Documentation

  • The README illustrates a simple example of dose adaptation
  • vignette("route_of_administration") shows how to select a route of administration for optimal dosing
  • vignette("population_models") describes the structure of prior population models written as model functions which can be parsed by rxode2 and used by posologyr
  • vignette("posologyr_user_defined_models") is renamed vignette("classic_posologyr_models")
  • Examples use rxode2 model functions

Bug fix

posologyr v1.2.4

CRAN release: 2024-02-09

  • Add ability to use rxode2 ui models for the poso_* functions. Once the model has been parsed by rxode2() with this package the model$posologyr gives the list needed for poso_* functions

posologyr v1.2.3

Bug fix

Documentation

posologyr v1.2.2

CRAN release: 2023-06-12

  • Relax the requirements of the NONMEM comparison test for time-varying covariates to account for computational differences observed with the alternative BLAS ATLAS on CRAN.

posologyr v1.2.1

CRAN release: 2023-06-05

  • Add a reference to Kang et al. (2012) doi:10.4196/kjpp.2012.16.2.97 in the DESCRIPTION (as requested by CRAN)
  • Fix messages to the console in the internal function posologyr() (as requested by CRAN)
  • Fix assignment to parent environment in dose optim functions, using parent.frame() (as requested by CRAN)

posologyr v1.2.0

Additional features

Documentation

  • vignette("a_priori_dosing") illustrates a priori dose selection
  • vignette("a_posteriori_dosing") illustrates a posteriori dose selection, using TDM data
  • vignette("auc_based_dosing") shows how to select an optimal dose for a given target AUC using data from TDM
  • vignette("multiple_endpoints") introduces the new multiple endpoints feature

Internal changes

  • The description of the package is updated

posologyr v1.1.0

Additional features

  • poso_time_cmin() can now estimate time needed to reach a selected trough concentration (Cmin) using the data from TDM directly
  • poso_dose_conc() can now estimate an optimal dose to reach a target concentration following the events from TDM
  • poso_dose_auc() can now estimate an optimal dose to reach a target auc following the events from TDM

posologyr v1.0.0

Breaking changes

  • posologyr() is now an internal function, all exported functions take patient data and a prior model as input parameters
  • The adaptive MAP forecasting option is removed

Additional features

  • poso_estim_map() provides an rxode2 model using MAP-EBE and the input dataset, with interpolation of covariates, to make plotting easier

Internal changes

  • RxODE import is updated to rxode2
  • All tests are updated to take into account the internalization of the posologyr() function

Bug fixes

posologyr v0.2.0

  • poso_estim_sir() estimates the posterior distribution of individual parameters by Sequential Importance Resampling (SIR). It is roughly 25 times faster than poso_estim_mcmc() for 1000 samples.
  • poso_estim_map() allows the estimation of the individual parameters by adaptive MAP forecasting (cf. doi: 10.1007/s11095-020-02908-7) with adapt=TRUE.
  • poso_simu_pop(), poso_estim_map(), and poso_estim_sir() now support models with both inter-individual (IIV) and inter-occasion variability (IOV).
  • MASS:mvrnorm is replaced by mvtnorm::rmvnorm for multivariate normal distributions.
  • Input validation is added to all exported functions.
  • poso_estim_map() now uses method=“L-BFGS-B” in optim for better convergence of the algorithm.
  • poso_inter_cmin() now uses method=“L-BFGS-B” in optim for better convergence of the algorithm.
  • poso_dose_conc() is the new name of poso_dose_ctime().
  • Issues #5 and #6 are fixed: poso_time_cmin(), poso_dose_auc(), poso_dose_conc(), and poso_inter_cmin() now work with prior and posterior distributions of ETA, and not only with point estimates (such as the MAP).
  • A new nocb parameter is added to posologyr(). The interpolation method for time-varying covariates can be either last observation carried forward (locf, the RxODE default), or next observation carried backward (nocb, the NONMEM default).
  • vignette("uncertainty_estimates") is removed.
  • The built-in models are removed.

posologyr v0.1.1

  • poso_time_cmin(), poso_dose_ctime(), and poso_dose_auc() now work for multiple dose regimen.
  • poso_inter_cmin() allows the optimization of the inter-dose interval for multiple dose regimen.
  • vignette("case_study_vancomycin") illustrates AUC-based optimal dosing, multiple dose regimen, and continuous intravenous infusion.

posologyr v0.1.0

First public release.